Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 864

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 2
Chunk 864
---
 (iii)
May 14, 2024, and (iv) July 16, 2024, the Company issued unsecured promissory notes (each, a “Sponsor Promissory
Note” and, collectively, the “Sponsor Promissory Notes”) to Bellevue Global Life Sciences Investors, LLC,
the Company’s sponsor (“Sponsor”), on (i) April 8, 2024, (ii) April 17, 2024, (iii) May 14,
2024, and (iv) July 11, 2024, in the principal amounts of (i) $1,200,000, (ii) $50,000, (iii) $140,000, and (iv) $300,000, respectively.
As previously reported by the Company on Form 8-K dated January 10, 2025, on January 9, 2025, the Company and Sponsor entered into
an amendment (the “Sponsor Promissory Notes Amendment”) to extend the maturity date of each Sponsor Promissory Note
to the earlier of (i) September 30, 2025 and (ii) the date on which the Company consummates an initial business combination.
No other terms of the Sponsor Promissory Notes were amended. The foregoing description of the Sponsor Promissory Notes Amendment is qualified
in its entirety by reference to the full text of the Promissory Notes Amendment, a copy of which is filed as Exhibit 10.1 to the Company’s
January 10, 2025 Current Report on Form 8-K and incorporated herein by reference.

On January 23, 2025, the Company and Sponsor entered into a second
amendment to amend the maturity date of each Sponsor Promissory Note to provide that each Sponsor Promissory Note matures on September
30, 2025, irrespective of whether the Company consummates an initial business combination prior to September 30, 2025. No other terms
of the Sponsor Promissory Notes were amended. The foregoing description of the Second Amendment to the Sponsor Promissory Notes is qualified
in its entirety by reference to the full text of the Second Amendment to the Sponsor Promissory Notes, a copy of which is filed as Exhibit
10.1 to the Company’s January 23, 2025 Current Report on Form 8-K and incorporated herein by reference.

As previously reported by the Company on Form